{"id":"W4410485030","doi":"10.1186/s40364-025-00784-0","title":"The progress and prospects of targeting the adenosine pathway in cancer immunotherapy","year":2025,"lang":"en","type":"review","venue":"Biomarker Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"SKiN Health","funders":"National Key Research and Development Program of China; Xiangya Hospital, Central South University; Natural Science Foundation of Hunan Province; China Postdoctoral Science Foundation; Natural Science Foundation for Distinguished Young Scholars of Hunan Province; National Natural Science Foundation of China","keywords":"Adenosinergic; Medicine; Immunotherapy; Tumor microenvironment; Adenosine; Cancer immunotherapy; Adenosine receptor; Clinical trial; Cancer; Immune system; Cancer research; Bioinformatics; Oncology; Immunology; Internal medicine; Biology; Receptor; Agonist","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002081522,0.0002054484,0.0004032128,0.0001160254,0.0001990628,0.00006549648,0.0005645213,0.0002247789,0.000008164767],"category_scores_gemma":[0.000167345,0.0001035373,0.0001307129,0.0005802578,0.0004416836,0.00000205003,0.0003981924,0.0003444809,5.419911e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002879674,"about_ca_system_score_gemma":0.0006344125,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001092066,"about_ca_topic_score_gemma":0.00002240537,"domain_scores_codex":[0.9978737,0.0006538365,0.0004098737,0.0003693867,0.0002944666,0.0003987688],"domain_scores_gemma":[0.9989101,0.0003154326,0.0001399191,0.0004375438,0.0001655039,0.00003146006],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001069827,0.00005933216,0.0002899971,0.005020436,0.000300772,0.000008515864,0.00004797697,2.136864e-7,0.000843172,0.0001504178,0.01282474,0.9803475],"study_design_scores_gemma":[0.0001798679,0.00006592134,0.00006208278,0.003153223,0.00001752571,0.00000465022,0.00003612016,0.000003217799,0.0007484054,0.00002148283,0.9955873,0.0001202148],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003818801,0.9979684,0.000002500919,0.0002352336,0.00007512479,0.00108496,0.00002066144,0.000004866742,0.0002263581],"genre_scores_gemma":[0.001479437,0.9962407,0.00001952334,0.000009305331,0.0001642758,0.0005809357,0.00003509536,0.00003756107,0.001433153],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9827626,"threshold_uncertainty_score":0.4222129,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0687544667880343,"score_gpt":0.423567058407508,"score_spread":0.3548125916194736,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}